# Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

> **NCT00594945** · PHASE2 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 45 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Clonazepam

## Key facts

- **NCT ID:** NCT00594945
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-12
- **Final completion:** 2009-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00594945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00594945, "Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00594945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*